eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community

  Tools   Community
All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms       Ask question       Write review       Answered/ Unanswered       Reviews       WellConnected

From FDA reports: drug interactions between Cellcept, Tacrolimus, Cyclophosphamide, Methylprednisolone Sodium Succinate, Alprostadil for a Male patient aged 47

This is a personalized study for a 47 year old male patient. The study is created by eHealthMe based on reports of 122 people who take the same drugs and have drug interactionsfrom FDA.

On Dec, 18, 2014: 122 people who reported to have interactions when taking Cellcept, Tacrolimus, Cyclophosphamide, Methylprednisolone Sodium Succinate, Alprostadil are studied

Trend of Cellcept, Tacrolimus, Cyclophosphamide, Methylprednisolone Sodium Succinate, Alprostadil's drug interactions, side effects, and effectiveness reports (3160959)

Information of the patient in this study:

Age: 47

Gender: male

Conditions: Prophylaxis Against Transplant Rejection

Drugs taking:
- Cellcept
- Tacrolimus
- Cyclophosphamide
- Methylprednisolone Sodium Succinate
- Alprostadil

Drug interactions have: Hepatic Neoplasm Malignant Recurrent

eHealthMe real world results:

Comparison with this patient's adverse outcomes among males aged 47 (±5):

InteractionNumber of reports
Hepatic Neoplasm Malignant Recurrent (liver cancer-recurrent)6 (85.71%)

Most common interactions experienced by males aged 47 (±5) in the use of Cellcept, Tacrolimus, Cyclophosphamide, Methylprednisolone Sodium Succinate, Alprostadil:

InteractionNumber of reports
Hepatic Neoplasm Malignant Recurrent (liver cancer-recurrent)6
Systemic Inflammatory Response Syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection)6
Pyrexia (fever)6
Metastases To Central Nervous System (cancer spreads to central nervous system)4
Visual Field Defect4
Cytomegalovirus Test Positive4
Depression4
Condition Aggravated (worse condition)4
Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi)4
Anaemia (lack of blood)4

Most common interactions experienced by males aged 47 (±5) in long term use of Cellcept, Tacrolimus, Cyclophosphamide, Methylprednisolone Sodium Succinate, Alprostadil:

InteractionNumber of reports
Metastases To Bone (cancer spreads to bone)2
Metastases To Central Nervous System (cancer spreads to central nervous system)2
Hepatic Neoplasm Malignant Recurrent (liver cancer-recurrent)2
Metastases To Abdominal Cavity (cancer spreads to abdominal cavity)2
Visual Field Defect2
Headache (pain in head)2
Visual Pathway Disorder2

For people in general (regardless of gender or age):

Comparison with this patient's adverse outcomes:

InteractionNumber of reports
Hepatic Neoplasm Malignant Recurrent (liver cancer-recurrent)6 (4.92%)

Most common interactions experienced by people in the use of Cellcept, Tacrolimus, Cyclophosphamide, Methylprednisolone Sodium Succinate, Alprostadil:

InteractionNumber of reports
Diarrhoea72
Acute Graft Versus Host Disease In Skin (acute complication on skin following an allogeneic tissue/blood transplant)52
Cytomegalovirus Viraemia (cytomegalo virus in blood stream)46
Pyrexia (fever)46
Neutropenia (an abnormally low number of neutrophils)42
Pruritus (severe itching of the skin)36
Acute Graft Versus Host Disease (acute complication following an allogeneic tissue/blood transplant)32
Bronchopulmonary Aspergillosis (lung disorder caused by aspergillus fungi)30
Staphylococcal Sepsis (blood infection by an infection with staphylococcus bacteria)30
Headache (pain in head)30

Most common interactions experienced by people in long term use of Cellcept, Tacrolimus, Cyclophosphamide, Methylprednisolone Sodium Succinate, Alprostadil:

InteractionNumber of reports
Hepatic Neoplasm Malignant Recurrent (liver cancer-recurrent)3
Metastases To Central Nervous System (cancer spreads to central nervous system)3
Headache (pain in head)3
Metastases To Bone (cancer spreads to bone)3
Metastases To Abdominal Cavity (cancer spreads to abdominal cavity)3
Visual Field Defect3
Oropharyngeal Pain2
Drug Interaction2
Arterial Thrombosis (formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system)2
Visual Pathway Disorder2

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

You can also:

NOTE: The study is based on active ingredients. Other drugs that have the same active ingredients are also considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

   

About - Terms of service - Privacy policy - Press - Testimonials - Contact us

 
© 2014 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.